Neuro-oncology: a selected review of ASCO 2016 abstracts.
ASCO 2016, 29 May-2 June 2016, Chicago, IL, USA The largest annual clinical oncology conference the American Society of Clinical Oncology is held in the USA and gives researchers and other key opinion leaders the opportunity to present new cancer clinical trials and research data. The CNS tumors section of the American Society of Clinical Oncology 2016 covered various aspects of neuro-oncology including metastatic CNS diseases and primary brain tumors, presented via posters, oral talks and over 100 abstracts. This brief review selectively highlights presentations from this meeting in an organizational manner that reflects clinically relevant aspects of a large and multifaceted meeting.
Department of Neurology/Division of Neuro-Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, 825 Eastlake Avenue E, POB 19023, MS G4940, Seattle, WA 98109-1023, USA.
Marc C
MC
Chamberlain
D016543:Central Nervous System Neoplasms / Q000150:complications / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology; D009462:Neurology; D012955:Societies, Medical; D014481:United States
ASCO 2016 CNS tumor abstracts; primary and secondary brain tumors